Shri Ahimsa Naturals FY26 PAT rises 37% to ₹30.08 crore
Shri Ahimsa Naturals Limited reported a 37% YoY increase in PAT to ₹30.08 crore for FY26, with revenue rising 30% to ₹123.32 crore. The Board approved a ₹70 crore capex increase for its Sawarda plant expansion, integrating new processes to enhance operational capabilities.

*this image is generated using AI for illustrative purposes only.
Shri Ahimsa Naturals Limited reported a 37% year-on-year increase in Profit After Tax (PAT) to ₹30.08 crore for the financial year ended March 31, 2026, driven by robust volume growth. Revenue from operations rose 30% to ₹123.32 crore, while EBITDA increased 18% to ₹35.8 crore, maintaining a strong margin of 29.1% despite elevated freight costs. The company, a leading global manufacturer of natural caffeine, attributed the performance to a 20% volume growth in natural caffeine and improved realizations.
The balance sheet remained strong with low debt and sound liquidity. Operational efficiency improved as debtor days reduced to 86 days from 96 days in FY25, and inventory days decreased to 193 days from 214 days. Cash flow from operations stood at ₹12.22 crore during the period. The Board of Directors approved the audited standalone and consolidated financial results for the year ended March 31, 2026, along with the appointment of M/s Rajesh & Company as Cost Auditor and M/s Sharma, Singh & Mehta as Internal Auditor for FY26-27.
Financial Performance
The following table summarizes the financial performance for the fiscal years 2024, 2025, and 2026:
| Fiscal Year | Revenue (₹ in Crs) | EBITDA (₹ in Crs) | PAT (₹ in Crs) | Natural Coffee Volume (in MTPA) |
|---|---|---|---|---|
| FY 2024 | 78 | 27 | 19 | 149 |
| FY 2025 | 96 | 30 | 22 | 164 |
| FY 2026 | 123.32 | 35.8 | 30.08 | 196 |
Expansion and Capex Plans
Shri Ahimsa Naturals is executing a greenfield expansion project at Sawarda, Jaipur, to scale manufacturing capabilities. The Board has approved the integration of additional facilities including a decaffeination process, Green Coffee Bean Extract (GCE) enrichment process, fungible botanical extraction process, and plant automation systems. These enhancements are expected to significantly improve operational capabilities and scalability.
The proposed upgrades entail an additional capital expenditure of up to ₹70 Crores. The funding structure includes ₹32.57 crore through preferential allotment of equity shares or warrants, ₹25 crore via bank term loan, and ₹12.43 crore from internal accruals. The new integrated facility is expected to commence operations by March 2027.
Current manufacturing capacity for natural caffeine stands at 270 MTPA, with capacity utilization at 72% in FY26, providing scope for incremental utilization to drive growth in FY27. The expansion strategy focuses on backward integration to ensure raw material security and cost competitiveness.
Historical Stock Returns for Shri Ahimsa Naturals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.66% | +3.97% | +12.92% | +13.92% | +88.44% | +105.10% |
How will the company manage the increased leverage from the ₹25 crore term loan while maintaining its current low-debt status?
What is the projected revenue contribution from the new decaffeination and GCE enrichment facilities once they become operational by March 2027?
Will the capacity utilization rate improve significantly in FY27 before the new greenfield facility comes online?



























